Cargando…

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection

There is a critical need for safe and effective drugs for COVID‐19. Only remdesivir has received authorization for COVID‐19 and has been shown to improve outcomes but not decrease mortality. However, the dose of remdesivir is limited by hepatic and kidney toxicity. ACE2 is the critical cell surface...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monteil, Vanessa, Dyczynski, Matheus, Lauschke, Volker M, Kwon, Hyesoo, Wirnsberger, Gerald, Youhanna, Sonia, Zhang, Haibo, Slutsky, Arthur S, Hurtado del Pozo, Carmen, Horn, Moritz, Montserrat, Nuria, Penninger, Josef M, Mirazimi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799356/ https://www.ncbi.nlm.nih.gov/pubmed/33179852 http://dx.doi.org/10.15252/emmm.202013426

Ejemplares similares

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
por: Monteil, Vanessa, et al.
Publicado: (2020)

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022)

Human recombinant soluble ACE2 in severe COVID-19
por: Zoufaly, Alexander, et al.
Publicado: (2020)

Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections
por: Monteil, Vanessa, et al.
Publicado: (2023)

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
por: Capraz, Tümay, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020)

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
por: Wirnsberger, Gerald, et al.
Publicado: (2021)

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
por: Zhu, Rong, et al.
Publicado: (2022)

Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
por: Zhu, Rong, et al.
Publicado: (2023)

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
por: Monteil, Vanessa, et al.
Publicado: (2022)

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
por: Gawish, Riem, et al.
Publicado: (2022)

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
por: Garreta, Elena, et al.
Publicado: (2022)

Redirecting Imipramine against Bluetongue Virus Infection: Insights from a Genome-wide Haploid Screening Study
por: John, Lijo, et al.
Publicado: (2022)

Generation of enzymatically competent SARS‐CoV‐2 decoy receptor ACE2‐Fc in glycoengineered Nicotiana benthamiana
por: Castilho, Alexandra, et al.
Publicado: (2021)

Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern
por: Onodera, Yu, et al.
Publicado: (2023)

The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
por: Zhu, JiaYi, et al.
Publicado: (2022)

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
por: Shoemaker, Robert H., et al.
Publicado: (2022)

Organotypic human ex vivo models for coronavirus disease 2019 research and drug development
por: Youhanna, Sonia, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
por: Perlot, Thomas, et al.
Publicado: (2013)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells
por: Garreta, Elena, et al.
Publicado: (2022)

Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients
por: Lee, Ji-Hyang, et al.
Publicado: (2022)

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)

Engineered soluble ACE2 receptor: Responding to change with change
por: Li, Guangyao, et al.
Publicado: (2023)

Recombinant human ACE2: acing out angiotensin II in ARDS therapy
por: Zhang, Haibo, et al.
Publicado: (2017)

Calcium measurements in enzymatically dissociated or mechanically microdissected mouse primary skeletal muscle fibers
por: Youhanna, Sonia, et al.
Publicado: (2023)

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
por: C., Selvaa Kumar, et al.
Publicado: (2020)

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020)

Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Genome-wide spatial expression profiling in formalin-fixed tissues
por: Gracia Villacampa, Eva, et al.
Publicado: (2021)

Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
por: Kuba, Keiji, et al.
Publicado: (2006)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
por: Kuba, Keiji, et al.
Publicado: (2005)

Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Yeung, Man Lung, et al.
Publicado: (2022)

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
por: Leow, Melvin Khee Shing
Publicado: (2020)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Dietary fish intake increased the concentration of soluble ACE2 in rats: can fish consumption reduce the risk of COVID-19 infection through interception of SARS-CoV-2 by soluble ACE2?
por: O’Keeffe, Maria, et al.
Publicado: (2023)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

Age and sex differences in soluble ACE2 may give insights for COVID-19
por: Swärd, Per, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a4h1dt9398t09ssfb5h4r4a8e8